5% Minoxidil

DRUG6 trials

Sponsors

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc., Dong-A ST Co., Ltd., University of Florida, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shenzhen People's Hospital

Conditions

AlopeciaAndrogenetic AlopeciaAndrogenetic Alopecia (AGA)Female Androgenetic Alopecia

Phase 1

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

CompletedNCT02280603

Dong-A ST Co., Ltd.Androgenetic Alopecia

Start: 2014-01-31End: 2014-12-31Updated: 2015-06-24

Phase 2

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

RecruitingNCT07370519

Shenzhen People's HospitalAndrogenetic Alopecia (AGA)

Start: 2026-01-25End: 2027-06-01Target: 388Updated: 2026-04-01

Phase 3

Clinical Trial in Females With Female Pattern Hair Loss

CompletedNCT01145625

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.Alopecia

Start: 2010-06-30End: 2012-02-29Updated: 2014-05-22

Phase 4

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

WithdrawnNCT02483195

University of FloridaFemale Androgenetic Alopecia

Start: 2016-08-31End: 2018-08-31Updated: 2016-09-02

Unknown Phase

Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAndrogenetic Alopecia

Start: 2023-11-24End: 2024-12-31Target: 135Updated: 2024-01-23

Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAndrogenetic Alopecia

Start: 2023-12-14End: 2024-12-31Target: 135Updated: 2024-01-23